Printer Friendly
The Free Library
14,599,074 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA bans natural thyroid millions need: action is FDA trademark.


We have learned that TIME-Cap Labs, producer of a generic version of the brand name drug Armour, a natural and bioidentical thyroid replacement, has been ordered by the FDA (Food and Drug Administration) to stop production. The FDA has decided to classify the company's product, available for over a century, as an unapproved new drug. Since the new drug approval process is prohibitively expensive for a non-patentable substance, the FDA is in effect banning the natural product. The purpose? Presumably to protect the profits of other, inferior drugs that have been FDA-approved. The FDA does not ban deadly pharmaceuticals, only that which is safe or effective.

COPYRIGHT 2009 The Gerson Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:United States Food and Drug Association; TIME-Cap Labs
Author:Gerson, Charlotte
Publication:Gerson Healing Newsletter
Article Type:Brief article
Geographic Code:1USA
Date:Nov 1, 2009
Words:106
Previous Article:Lisa beats melanoma in two years: Lisa Mendoza's victory over deadly cancer.
Next Article:Board, G.I.F.T., happy growth, Hungary, new staff.(From the desk of Anita Wilson, Executive Director)(Gerson International Friends Team)
Topics:



Related Articles
Concerned about generic drugs? Check the orange book! (Approved Drug Products with Therapeutic Equivalence Evaluations)
Labs face aftermath of Abbott's consent decree with FDA.(Brief Article)
State Senate approves ban on ephedra-based products: Metabolife says decision would deprive consumers of choices. (Health).
Advertising new drug at issue with Amylin: attorney says FDA is hurting firm's ability to market Symlin.(Biotech)
100 years of FDA.
FDA amendments give agency broad powers over drug safety, ad fines.(FDA reform)(Food and Drug Administration)
Potency specifications for thyroid drugs tightened.(Drug Safety)
American Hormones.(HUMAN DRUGS)
Cephalon Files Patent Infringement Lawsuit Against Watson.
Bioidentical hormones, estriol, and the FDA.(Shorts)(Food and Drug Administration)(Report)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles